Drug Name | Active Ingredient | Dosage Form | Company | Country/Region | Strength | Registration No. | Date Issued | Details |
---|---|---|---|---|---|---|---|---|
吸入用布地奈德混悬液 | budesonide | Suspension | view | view | view | H20140475 | 2019-05-22 | view |
吸入用布地奈德混悬液 | budesonide | Suspension | view | view | view | H20140474 | 2019-05-22 | view |
美沙拉秦缓释片 | mesalazine | Tablet, extended release | view | view | view | H20181183 | 2018-04-12 | view |
西妥昔单抗注射液 | Cetuximab | Injection | view | view | view | S20171039 | 2017-12-27 | view |
来曲唑片 | letrozole | Tablet | view | view | view | H20140149 | 2019-02-19 | view |
淀粉乳糖 | Excipients | view | view | view | F20160003 | 2016-08-02 | view | |
酒石酸长春瑞滨软胶囊 | Vinorelbine ditartrate | Soft capsules | view | view | view | H20140658 | 2019-05-07 | view |
酒石酸长春瑞滨软胶囊 | Vinorelbine ditartrate | Soft capsules | view | view | view | H20140657 | 2019-05-07 | view |
托吡酯 | topiramate | Active ingredient | view | view | view | H20160362 | 2016-07-05 | view |
托伐普坦喷雾干燥粉末 | tolvaptan | Spray | view | view | view | H20160389 | 2016-07-05 | view |
托伐普坦喷雾干燥粉末 | tolvaptan | Spray | view | view | view | H20160390 | 2016-07-05 | view |
氯替泼诺混悬滴眼液 | loteprednol | Suspension | view | view | view | H20160347 | 2020-06-11 | view |
氯替泼诺混悬滴眼液 | loteprednol | Suspension | view | view | view | H20160348 | 2020-06-11 | view |
氯替泼诺混悬滴眼液 | loteprednol | Suspension | view | view | view | H20180059 | 2018-10-23 | view |
氯替泼诺混悬滴眼液 | loteprednol | Suspension | view | view | view | H20191002 | 2019-01-14 | view |
氯替泼诺混悬滴眼液 | loteprednol | Suspension | view | view | view | J20160099 | 2016-12-21 | view |
氯替泼诺混悬滴眼液 | loteprednol | Suspension | view | view | view | H20160346 | 2020-06-11 | view |
倍氯米松福莫特罗吸入气雾剂 | beclometasone;formoterol | Aerosol | view | view | view | H20181177 | 2018-09-17 | view |
多西他赛注射液 | Docetaxel | Injection | view | view | view | H20140944 | 2018-10-16 | view |
多西他赛注射液 | Docetaxel | Injection | view | view | view | H20140086 | 2018-10-15 | view |